Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

NEW
STU:4E2 (USA)  
€ 3.78 +0.080 (+2.16%) Sep 4
At Loss
P/B:
2.29
Market Cap:
€ 406.39M ($ 472.22M)
Enterprise V:
€ 219.14M ($ 254.64M)
Volume:
0
Avg Vol (2M):
3.67K
Trade In:

Relmada Therapeutics Inc Valuation Measures